These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1435 related articles for article (PubMed ID: 30803823)

  • 1. mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases.
    Maruggi G; Zhang C; Li J; Ulmer JB; Yu D
    Mol Ther; 2019 Apr; 27(4):757-772. PubMed ID: 30803823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in mRNA Vaccines for Infectious Diseases.
    Zhang C; Maruggi G; Shan H; Li J
    Front Immunol; 2019; 10():594. PubMed ID: 30972078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination with Messenger RNA: A Promising Alternative to DNA Vaccination.
    Tombácz I; Weissman D; Pardi N
    Methods Mol Biol; 2021; 2197():13-31. PubMed ID: 32827130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-amplifying mRNA-Based Vaccine Technology and Its Mode of Action.
    Maruggi G; Ulmer JB; Rappuoli R; Yu D
    Curr Top Microbiol Immunol; 2022; 440():31-70. PubMed ID: 33861374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mRNA Vaccine Development for Emerging Animal and Zoonotic Diseases.
    Le T; Sun C; Chang J; Zhang G; Yin X
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging skin-targeted drug delivery strategies to engineer immunity: A focus on infectious diseases.
    Korkmaz E; Balmert SC; Carey CD; Erdos G; Falo LD
    Expert Opin Drug Deliv; 2021 Feb; 18(2):151-167. PubMed ID: 32924651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innovative Strategies to Enhance mRNA Vaccine Delivery and Effectiveness: Mechanisms and Future Outlook.
    Verma A; Awasthi A
    Curr Pharm Des; 2024; 30(14):1049-1059. PubMed ID: 38551046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Advances in the Molecular Design and Delivery Technology of mRNA for Vaccination Against Infectious Diseases.
    Yang L; Tang L; Zhang M; Liu C
    Front Immunol; 2022; 13():896958. PubMed ID: 35928814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-assembled mRNA vaccines.
    Kim J; Eygeris Y; Gupta M; Sahay G
    Adv Drug Deliv Rev; 2021 Mar; 170():83-112. PubMed ID: 33400957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of RNA-based treatments in the field of cancer immunotherapy.
    Chehelgerdi M; Chehelgerdi M
    Mol Cancer; 2023 Jul; 22(1):106. PubMed ID: 37420174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mRNA vaccines for infectious diseases: principles, delivery and clinical translation.
    Chaudhary N; Weissman D; Whitehead KA
    Nat Rev Drug Discov; 2021 Nov; 20(11):817-838. PubMed ID: 34433919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mRNA vaccine delivery using lipid nanoparticles.
    Reichmuth AM; Oberli MA; Jaklenec A; Langer R; Blankschtein D
    Ther Deliv; 2016; 7(5):319-34. PubMed ID: 27075952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Messenger RNA-Based Vaccines Against Infectious Diseases.
    Alameh MG; Weissman D; Pardi N
    Curr Top Microbiol Immunol; 2022; 440():111-145. PubMed ID: 32300916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New Hopes in Vaccine Technology: mRNA Vaccines].
    Yılmaz E
    Mikrobiyol Bul; 2021 Apr; 55(2):265-284. PubMed ID: 33882657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current state of, prospects for, and obstacles to mRNA vaccine development.
    Aljabali AAA; Bashatwah RM; Obeid MA; Mishra V; Mishra Y; Serrano-Aroca Á; Lundstrom K; Tambuwala MM
    Drug Discov Today; 2023 Feb; 28(2):103458. PubMed ID: 36427779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticle Vaccines Against Infectious Diseases.
    Pati R; Shevtsov M; Sonawane A
    Front Immunol; 2018; 9():2224. PubMed ID: 30337923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-amplifying mRNA vaccines.
    Brito LA; Kommareddy S; Maione D; Uematsu Y; Giovani C; Berlanda Scorza F; Otten GR; Yu D; Mandl CW; Mason PW; Dormitzer PR; Ulmer JB; Geall AJ
    Adv Genet; 2015; 89():179-233. PubMed ID: 25620012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccines 'on demand': science fiction or a future reality.
    Ulmer JB; Mansoura MK; Geall AJ
    Expert Opin Drug Discov; 2015 Feb; 10(2):101-6. PubMed ID: 25582273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New approaches in vaccine development.
    Leclerc C
    Comp Immunol Microbiol Infect Dis; 2003 Oct; 26(5-6):329-41. PubMed ID: 12818620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines.
    Deering RP; Kommareddy S; Ulmer JB; Brito LA; Geall AJ
    Expert Opin Drug Deliv; 2014 Jun; 11(6):885-99. PubMed ID: 24665982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 72.